CLOV vs LFCR · rev $1.37B vs $207.1M cap
Clover Health Investments Corp (CLOV) versus Lifecore Biomedical Inc. (LFCR) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
LFCR does not have a complete income-statement cache yet.
CLOV currently screens at market cap $1.55B. LFCR currently screens at market cap $207.1M.
Not investment advice. Open the CLOV and LFCR stock pages for the full models.
Not investment advice.